Lopital
Lopital is one of the market leaders in the Netherlands in the field of innovative hygiene and transfer aids to prevent physical overload and reduce work pressure within healthcare organizations.
About Lopital
Founded in 1977, Lopital operates in more than 25 countries with a team of 47 employees. Lopital develops, assembles and implements a wide range of durable, (MDR) certified and high quality devices to prevent physical overload and reduce work pressure within healthcare facilities, hospitals and home care. Lopital products have a major impact on the well-being and health of clients and healthcare workers.
In June 2026, Lopital acquired Culsana. This strategic add-on expands Lopital’s product portfolio and strengthens the company’s position in the institutional healthcare sector.
Why are we investing in Lopital?
There stands a powerful company with an excellent foundation from which we will realize our growth ambitions. Holland Capital supports the organization in its growth plans by focusing on both organic growth (portfolio development), the development of new business models and value propositions, and buy-and-build opportunities, and that nationally and internationally.
Add on
“With the addition of Culsana, we create immediate commercial synergies through our complementary product portfolios and shared customer base. This acquisition fits perfectly within our buy-and-build strategy, through which we continue to expand our offering with proprietary, complementary products for the healthcare sector.”
– Jan van Megen, CEO Lopital
Healthcare portfolio
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.de